(E)-ethyl 3-cyclopentylprop-2-enoate | 2931-23-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (E)-ethyl 3-cyclopentylprop-2-enoate
• 英文别名: (E)-ethyl 3-cyclopentylpropenoate；(E)-ethyl 3-cyclopentylacrylate；ethyl 3-cyclopentylpropenoate；(E)-3-cyclopentyl-acrylic acid ethyl ester；3-Cyclopentyl-propensaeure-aethylester；ethyl (E)-3-cyclopentylprop-2-enoate
• CAS: 2931-23-9；17343-83-8
• 化学式: C₁₀H₁₆O₂
• 分子量: 168.236
• InChiKey: VIBBHFMKHPIDMC-BQYQJAHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (E)-ethyl 3-cyclopentylprop-2-enoate 在 (isomerization) 作用下， 生成 ethyl 3-cyclopentylidenepropanoate
  参考文献：
  名称：

  Reaction of epoxides with tri-n-butylcarbethoxymethylidenephosphorane. Formation of unsaturated esters

  摘要：

  DOI：

  10.1021/ja00999a020
• 作为产物：
  描述：

  环戊基甲醇 在 Celite 、 sodium hydride 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 18.0h， 生成 (E)-ethyl 3-cyclopentylprop-2-enoate
  参考文献：
  名称：

  Synthesis of novel cyclopropylic sulfones and sulfonamides acting as glucokinase activators

  摘要：

  A synthetic route towards cyclopropylic compounds, which act as glucokinase activators is described herein. The present synthesis gives easy and rapid access to a wide variety of either sulfones or sulfonamides starting from readily available late-stage intermediates. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2006.02.110

文献信息

• The photomediated reaction of alkynes with cycloalkanes
  作者：Roísín A. Doohan、John J. Hannan、Niall W. A. Geraghty

  DOI：10.1039/b517631j

  日期：——

  of a photomediator such as benzophenone, alkynes with electron-withdrawing groups react with cycloalkanes to give vinyl cycloalkanes. The reaction involves the regiospecific addition of a photochemically generated cycloalkyl radical to the beta-carbon of the alkyne. The stereochemical outcome of the reaction depends on the nature of the photomediator and alkyne used.

  在光介体如二苯甲酮的存在下，具有吸电子基团的炔烃与环烷烃反应生成乙烯基环烷烃。该反应涉及将光化学产生的环烷基的区域特异性加成到炔烃的β-碳上。反应的立体化学结果取决于所使用的光介体和炔烃的性质。
• Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
  作者：Roland W. Bürli、Christopher A. Luckhurst、Omar Aziz、Kim L. Matthews、Dawn Yates、Kathy. A. Lyons、Maria Beconi、George McAllister、Perla Breccia、Andrew J. Stott、Stephen D. Penrose、Michael Wall、Marieke Lamers、Philip Leonard、Ilka Müller、Christine M. Richardson、Rebecca Jarvis、Liz Stones、Samantha Hughes、Grant Wishart、Alan F. Haughan、Catherine O’Connell、Tania Mead、Hannah McNeil、Julie Vann、John Mangette、Michel Maillard、Vahri Beaumont、Ignacio Munoz-Sanjuan、Celia Dominguez

  DOI：10.1021/jm4011884

  日期：2013.12.27

  Inhibition of class IIa histone deacetylase (HDAC) enzymes have been suggested as a therapeutic strategy for a number of diseases, including Huntington’s disease. Catalytic-site small molecule inhibitors of the class IIa HDAC4, -5, -7, and -9 were developed. These trisubstituted diarylcyclopropanehydroxamic acids were designed to exploit a lower pocket that is characteristic for the class IIa HDACs

  有人提出抑制IIa类组蛋白脱乙酰基酶（HDAC）酶可以作为许多疾病的治疗策略，包括亨廷顿氏病。开发了IIa类HDAC4，-5，-7和-9的催化位点小分子抑制剂。这些三取代的二芳基环丙烷异羟肟酸被设计用于开发IIa类HDAC特有的下部口袋，而其他HDAC类中不存在。所选的抑制剂与人HDAC4的催化结构域共结晶。我们以“闭环”形式描述了第一个HDAC4催化域晶体结构，在我们看来代表了生物学相关的构象。我们已经证明这些分子可以区分IIa类HDAC与I类和IIb类亚型。它们表现出药代动力学特性，应该能够评估它们在周围和中枢神经系统疾病中的治疗效果。这些选择性抑制剂提供了用于评估体内临床前模型中潜在功效的手段。
• [EN] HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS D'HISTONE DÉSACÉTYLASE, ET COMPOSITIONS ET PROCÉDÉS POUR LES UTILISER
  申请人：CHDI FOUNDATION INC

  公开号：WO2012103008A1

  公开（公告）日：2012-08-02

  Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, compositions thereof, and methods of their use.

  提供了某些Formula I的组蛋白去乙酰化酶（HDAC）抑制剂，以及它们的组合物和使用方法。
• [EN] SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS<br/>[FR] ARYLCYCLOPROPYLACETAMIDES SUBSTITUES SERVANT D'ACTIVATEURS DE GLUCOKINASE
  申请人：LILLY CO ELI

  公开号：WO2004063179A1

  公开（公告）日：2004-07-29

  According to the present invention there is provided a compounds of formula (I): and pharmaceutically acceptable salts thereof.

  根据本发明提供了以下式(I)的化合物及其药用可接受的盐。
• A convenient and mild chromatography-free method for the purification of the products of Wittig and Appel reactions
  作者：Peter A. Byrne、Kamalraj V. Rajendran、Jimmy Muldoon、Declan G. Gilheany

  DOI：10.1039/c2ob07074j

  日期：——

  A mild method for the facile removal of phosphine oxide from the crude products of Wittig and Appel reactions is described. Work-up with oxalyl chloride to generate insoluble chlorophosphonium salt (CPS) yields phosphorus-free products for a wide variety of these reactions. The CPS product can be further converted into phosphine.

  描述了一种温和的方法，可以方便地从Wittig和Appel反应的粗产物中去除磷烷氧化物。使用草酰氯进行后处理，生成不溶的氯磷铵盐（CPS），从而为多种反应提供无磷产品。CPS产物可以进一步转化为磷烷。